What is the latest NIDAN stock price?
The latest stored price for NIDAN is Rs 13.40 as of 2026-09-18.
gimli
NIDAN stock AI analysis
NIDAN Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
NIDAN LABS AND HEALTH LTD is a small-cap stock in Unclassified. This Gimli page shows the latest available NIDAN price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹13.40
1W return
+1.90%
1M return
-0.74%
3M return
-0.74%
6M return
-8.22%
1Y return
-30.93%
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
+2.95%
ROCE
+6.12%
RSI
49.02
Turnover
₹0.01 cr
Why it can matter in screens
- Momentum: NIDAN is below 50DMA, below 200DMA; RSI is 49.02.
- Returns: 1D +3.08%, 1W +1.90%, 1M -0.74%, 3M -0.74%, 1Y -30.93%.
- Trend levels: 52W high ₹24.90, 52W low ₹11.50, off high -46.18%.
- Liquidity: latest turnover is ₹0.01 cr; volume vs 20D is +0.37%.
- Valuation/profitability: PE n/a, PB n/a, ROE +2.95%, ROCE +6.12%.
- Growth: 3Y sales CAGR -6.13%, 3Y profit CAGR -9.37%.
Quick Answers
Is NIDAN above its 50DMA and 200DMA?
NIDAN is below 50DMA, below 200DMA. The latest 50DMA is 13.48 and the latest 200DMA is 15.85.
What are NIDAN PE, ROE and ROCE?
NIDAN has PE n/a, ROE +2.95%, and ROCE +6.12% in Gimli's latest available snapshot.
How has NIDAN performed recently?
NIDAN has returned -0.74% over 1 month, -0.74% over 3 months, and -30.93% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 24.53 cr | 7.24 cr | 1.98 cr | 1.42 |
| 2024-03-31 | 24.18 cr | 2.58 cr | -3.23 cr | -2.33 |
| 2023-03-31 | 24.27 cr | 10.00 cr | 3.54 cr | 2.55 |
| 2022-03-31 | 29.66 cr | 9.59 cr | 2.66 cr | 2.32 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-03-31 | 82.94 cr | 1.90 cr | 11.11 cr | 68.18 cr |
| 2024-03-31 | 82.55 cr | 2.85 cr | 12.43 cr | 66.21 cr |
| 2023-03-31 | 84.40 cr | 8.42 cr | 10.93 cr | 69.44 cr |
| 2022-03-31 | 88.48 cr | 8.10 cr | 19.29 cr | 65.90 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-03-31 | 2.28 cr | 1.34 cr | n/a |
| 2024-03-31 | 5.52 cr | 4.78 cr | n/a |
| 2023-03-31 | 10.97 cr | 10.30 cr | n/a |
| 2022-03-31 | 7.83 cr | 0.75 cr | n/a |
Shareholding Trend
No recent data available.
Industry Peers
No recent data available.
Try these prompts
- Analyze NIDAN LABS AND HEALTH with valuation, momentum and industry peers
- Compare NIDAN with other Unclassified stocks
- Show small-cap stocks in Unclassified above 50DMA with positive 1M return
- Find Unclassified stocks with improving momentum and reasonable valuation
Related screen ideas
- View Unclassified stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare NIDAN with other Unclassified stocks
Data snapshot: 2026-09-18. Not investment advice.